SUNSHINE HEALTHCARE LANKA LIMITED — Ranitidine Importer Profile
Pharmaceutical Importer · #14 buyer for Ranitidine · $305.1K import value · 32 shipments · SRI LANKA · DGFT Verified
SUNSHINE HEALTHCARE LANKA LIMITED is the #14 importer of Ranitidine from India with $305.1K in import value and 32 verified shipments. SUNSHINE HEALTHCARE LANKA LIMITED holds a 1.2% market share in Ranitidine imports based in SRI LANKA. The company sources from 1 verified supplier across 21 formulations shipped to 1 country. Overall, SUNSHINE HEALTHCARE LANKA LIMITED imports 11 pharmaceutical products worth $22.5M across 8 therapeutic categories.
SUNSHINE HEALTHCARE LANKA LIMITED — Ranitidine Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ranitidine to SUNSHINE HEALTHCARE LANKA LIMITED?
Verified from 32 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CADILA PHARMACEUTICALS LIMITED | $305.1K | 32 | 100.0% |
SUNSHINE HEALTHCARE LANKA LIMITED sources Ranitidine from 1 verified Indian supplier based on 32 customs records. The primary supplier is CADILA PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
How Does SUNSHINE HEALTHCARE LANKA LIMITED Compare to Nearest Ranitidine Importers?
Buyers ranked immediately above and below #14 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | ASPEN PHARMACARE PTY LTD., | AUSTRALIA | $196.2K | 4 | $49.0K |
| 13 | KONARK INTELMED LIMITED | POLAND | $191.5K | 20 | $9.6K |
| 14 | SUNSHINE HEALTHCARE LANKA LIMITED ★ | SRI LANKA | $154.4K | 24 | $6.4K |
| 3 | UNIVERSAL CO. LTD. | MYANMAR | $150.0K | 3 | $50.0K |
| 15 | PHARMACEUTICAL PRODUCTS LTD | MYANMAR | $134.1K | 12 | $11.2K |
SUNSHINE HEALTHCARE LANKA LIMITED ranks #14 among 533 Ranitidine importers from India. Average shipment value of $6.4K compared to the market average of $9.4K. The closest competitors by value are ASPEN PHARMACARE PTY LTD., and KONARK INTELMED LIMITED.
Where Does SUNSHINE HEALTHCARE LANKA LIMITED Import Ranitidine To?
Destination countries from 32 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| SRI LANKA | $305.1K | 32 | 100.0% |
SUNSHINE HEALTHCARE LANKA LIMITED imports Ranitidine to 1 country. The primary destination is SRI LANKA receiving 100.0% of shipments worth $305.1K.
What Ranitidine Formulations Does SUNSHINE HEALTHCARE LANKA LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| PHA DRG & MED ACILOC 150 CONT. RANITIDINE HCL TABLETS USP (150MG) QTY. 100T/PAC | $99.6K | 6 |
| PHA DRG & MED ACILOC 150 TAB. CONT. RANITIDINE HCL TABLETS USP (150MG) QTY. 100T/PAC | $73.6K | 2 |
| ACILOC 150 (R/M : RANITIDINE HCL TABLETS USP (150MG) BATCH N683005B/N68E3006 MFG DT-NOV-2023 EXP DT-OCT-2026 | $27.4K | 1 |
| ACILOC 150 (R/M : RANITIDINE HCL TABLETS | $23.6K | 2 |
| ACILOC 150 ( RAW MATERIAL : RANITIDINE H | $17.2K | 1 |
| PHA DRG & MED ACILOC 150 TAB. CONT. RANITIDINE HCL TABLETS USP 150MG QTY. 100T/PAC | $13.8K | 1 |
| PHA DRG MED ACILOC 150 TAB CONT RANITIDINE HCL TABLETS USP 150MG QTY 100T PAC | $10.0K | 1 |
| PHA DRG & MED ACILOC 300 TB. CONT. RANITIDINE HCL TABLETS USP QTY. 100T/PAC | $9.7K | 1 |
| ACILOC 150 (RAW MATERIAL : RANITIDINE HC | $8.0K | 2 |
| ACILOC 300 (R/M : RANITIDINE HCL TABLETS U) BATCH R53E3002 MFG DT-NOV-2023 EXP DT-OCT-2026 | $5.7K | 1 |
SUNSHINE HEALTHCARE LANKA LIMITED imports 21 distinct Ranitidine formulations from India. The top formulation is PHA DRG & MED ACILOC 150 CONT. RANITIDINE HCL TABLETS USP (1 with 6 shipments worth $99.6K.
Who Are the Top Buyers of Ranitidine from India and How Much Does SUNSHINE HEALTHCARE LANKA LIMITED Import?
India exported $5.0M worth of Ranitidine through 1,996 shipments from 248 suppliers to 104 countries, serving 533 buyers globally. SUNSHINE HEALTHCARE LANKA LIMITED imports $305.1K of this total, accounting for 1.2% of India's Ranitidine exports with 32 shipments from SRI LANKA. This is verified from 32 customs shipment records covering 21 distinct formulations.
What Is the Average Order Value for SUNSHINE HEALTHCARE LANKA LIMITED's Ranitidine Imports?
SUNSHINE HEALTHCARE LANKA LIMITED's average Ranitidine order value is $9.5K per consignment, based on 32 shipments totaling $305.1K. SUNSHINE HEALTHCARE LANKA LIMITED is based in SRI LANKA and ranks #14 among all Ranitidine importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Ranitidine to SUNSHINE HEALTHCARE LANKA LIMITED?
SUNSHINE HEALTHCARE LANKA LIMITED sources Ranitidine from 1 verified Indian supplier: CADILA PHARMACEUTICALS LIMITED ($305.1K, 100.0%). This is based on 32 customs records.
How Does SUNSHINE HEALTHCARE LANKA LIMITED Compare to Other Ranitidine Importers?
SUNSHINE HEALTHCARE LANKA LIMITED ranks #14 among 533 Ranitidine importers from India with a 1.2% market share. The top 3 importers are MARCAN PHARMACEUTICALS INC. ($1.2M), MARCAN PHARMACEUTICALS INC ($712.7K), BIOMEDIKAL LLC ($501.7K). SUNSHINE HEALTHCARE LANKA LIMITED processed 32 shipments from SRI LANKA.
What Other Gastrointestinal Products Does SUNSHINE HEALTHCARE LANKA LIMITED Import?
SUNSHINE HEALTHCARE LANKA LIMITED also imports these gastrointestinal products. Each links to the detailed product page.
About SUNSHINE HEALTHCARE LANKA LIMITED
SUNSHINE HEALTHCARE LANKA LIMITED imports 11 products worth $22.5M. Beyond Ranitidine, top products include Atorvastatin, Calcium, Losartan, Pantoprazole, Theophylline. View the complete SUNSHINE HEALTHCARE LANKA LIMITED profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ranitidine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ranitidine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: SUNSHINE HEALTHCARE LANKA LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as SUNSHINE HEALTHCARE LANKA LIMITED's capped import value divided by total capped export value for Ranitidine across all Indian exporters.
- 5.Verified Records: This page is backed by 32 individual customs records matching SUNSHINE HEALTHCARE LANKA LIMITED importing Ranitidine, covering 21 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 104+ countries, 533+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ranitidine Import Data for SUNSHINE HEALTHCARE LANKA LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for SUNSHINE HEALTHCARE LANKA LIMITED's Ranitidine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUNSHINE HEALTHCARE LANKA LIMITED
Full Company Profile →
11 products · $22.5M total trade · 8 categories
SUNSHINE HEALTHCARE LANKA LIMITED × Ranitidine
Verified from customs records
Company Overview
Top Products by SUNSHINE HEALTHCARE LANKA LIMITED
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for SUNSHINE HEALTHCARE LANKA LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ranitidine. For current order-level data, contact TransData Nexus.